RXST
RxSight, Inc.$5.64-0.46 (-7.45%)Prev Close$6.11·MCap$249.2M·P/E—·Vol435.4K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
4
$118.0K
◆
Net Activity
Net Seller
$118.0K
●
Active Insiders
4
last 12 mo
Over the past 12 months, insider activity at RxSight, Inc. (RXST) has been exclusively selling, with 0 insider purchases totaling $0.00 and 4 insider sales totaling $118.0K. The most recent insider transaction was by Goldshleger Ilya (officer: Chief Operating Officer), who sold $14.2K worth of shares on Sep 2, 2026. RxSight, Inc. operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $249.2M.
RXST Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Goldshleger Ilya | officer: Chief Operating Officer | Sell | 2,041 | $6.96 | $14.2K | 81,509 |
| Sep 2, 2026 | Kurtz Ronald M MD | officer: Chief Medical Officer | Sell | 5,100 | $6.96 | $35.5K | 71,775 |
| Sep 2, 2026 | Weinberg Eric | officer: See remarks | Sell | 2,041 | $6.96 | $14.2K | 200,348 |
| Sep 2, 2026 | Wilterding Mark | officer: Chief Financial Officer | Sell | 7,765 | $6.96 | $54.0K | 25,049 |
| Mar 12, 2025 | Fountain Tamara | Director | Sell | 7,000 | $25.71 | $180.0K | 0 |
| Jan 27, 2025 | Maniar Shweta | Sell | 3,519 | $30.87 | $108.6K | 7,383-32% | |
| Jan 17, 2025 | Corley Jesse Anderson | Buy | 3,210 | $31.15 | $100.0K | 3,210 | |
| Dec 3, 2024 | Goldshleger Ilya | See remarks | Sell | 3,105 | $46.08 | $143.1K | 42,246 |
| Nov 26, 2024 | Goldshleger Ilya | See remarks | Sell | 6,200 | $45.44 | $281.7K | 42,246 |
| Nov 26, 2024 | Maniar Shweta | Sell | 3,782 | $45.88 | $173.5K | 10,902-26% | |
| Nov 18, 2024 | Goldshleger Ilya | See remarks | Sell | 7,975 | $45.61 | $363.8K | 42,279 |
| Nov 14, 2024 | Corley Jesse Anderson | Buy | 22,476 | $45.14 | $1.01M | 474,141 | |
| Nov 14, 2024 | Goldshleger Ilya | See remarks | Sell | 1,330 | $46.13 | $61.4K | 42,246 |
| Nov 8, 2024 | Goldshleger Ilya | See remarks | Sell | 3,100 | $55.00 | $170.5K | 42,446 |
| Nov 5, 2024 | Goldshleger Ilya | See remarks | Sell | 3,100 | $51.05 | $158.2K | 42,506 |
| Oct 31, 2024 | Goldshleger Ilya | See remarks | Sell | 3,105 | $51.91 | $161.2K | 42,246 |
| Oct 28, 2024 | Goldshleger Ilya | See remarks | Sell | 6,200 | $50.22 | $311.4K | 42,246 |
| Oct 22, 2024 | Goldshleger Ilya | See remarks | Sell | 3,100 | $49.68 | $154.0K | 42,246 |
| Oct 18, 2024 | Goldshleger Ilya | See remarks | Sell | 6,205 | $49.94 | $309.9K | 42,349 |
| Oct 15, 2024 | Goldshleger Ilya | See remarks | Sell | 9,305 | $49.70 | $462.5K | 42,246 |
| Oct 8, 2024 | Goldshleger Ilya | See remarks | Sell | 6,200 | $48.13 | $298.4K | 42,480 |
| Oct 2, 2024 | Thunen Shelley B | See remarks | Sell | 15,000 | $48.45 | $726.7K | 40,242-27% |
| Sep 30, 2024 | Goldshleger Ilya | See remarks | Sell | 6,205 | $49.15 | $305.0K | 43,694 |
| Sep 23, 2024 | Goldshleger Ilya | See remarks | Sell | 6,200 | $52.93 | $328.2K | 42,396 |
| Sep 18, 2024 | Goldshleger Ilya | See remarks | Sell | 3,100 | $56.11 | $173.9K | 42,246 |
| Aug 6, 2024 | Goldshleger Ilya | See remarks | Sell | 9,000 | $39.25 | $353.3K | 50,101 |
| Jul 2, 2024 | Thunen Shelley B | Chief Financial Officer | Sell | 18,402 | $58.68 | $1.08M | 15,792-54% |
| Jun 17, 2024 | Andrews Julie | Sell | 15,625 | $58.00 | $906.3K | 33,972-32% | |
| May 21, 2024 | Tammenoms Bakker Juliet | Buy | 5,000 | $61.09 | $305.5K | 34,840 | |
| May 6, 2024 | Kurtz Ronald M MD | President & CEO | Sell | 40,000 | $60.15 | $2.41M | 764,610 |
| May 2, 2024 | Thunen Shelley B | Chief Financial Officer | Sell | 10,000 | $52.69 | $526.9K | 14,318-41% |
| Apr 2, 2024 | Thunen Shelley B | Chief Financial Officer | Sell | 20,000 | $49.90 | $997.9K | 19,545-51% |
| Mar 5, 2024 | Thunen Shelley B | Chief Financial Officer | Sell | 10,000 | $56.37 | $563.7K | 22,525-31% |
| Feb 16, 2024 | Goldshleger Ilya | Chief Operating Officer | Sell | 25,000 | $54.00 | $1.35M | 31,475-44% |
| Feb 15, 2024 | Tammenoms Bakker Juliet | Buy | 8,000 | $50.83 | $406.7K | 29,840+37% | |
| Feb 12, 2024 | Goldshleger Ilya | Chief Operating Officer | Sell | 10,365 | $50.74 | $525.9K | 31,475 |
| Feb 7, 2024 | Thunen Shelley B | Chief Financial Officer | Sell | 15,875 | $47.47 | $753.6K | 13,691-54% |
| Feb 2, 2024 | Goldshleger Ilya | Chief Operating Officer | Sell | 7,129 | $49.29 | $351.4K | 30,065 |
| Feb 2, 2024 | LINK WILLIAM J PHD | Sell | 28,250 | $49.67 | $1.40M | 31,900-47% | |
| Feb 2, 2024 | Weinberg Eric | Chief Commercial Officer | Sell | 10,000 | $50.00 | $500.0K | 299,978 |
| Jan 29, 2024 | Thunen Shelley B | Chief Financial Officer | Sell | 31,772 | $47.11 | $1.50M | 6,791-82% |
| Jan 22, 2024 | Goldshleger Ilya | Chief Operating Officer | Sell | 5,000 | $48.00 | $240.0K | 26,475 |
| Jan 22, 2024 | Weinberg Eric | Chief Commercial Officer | Sell | 10,000 | $48.00 | $480.0K | 309,978 |
| Jan 19, 2024 | Maniar Shweta | Sell | 6,399 | $45.72 | $292.6K | 15,009-30% | |
| Jan 10, 2024 | Goldshleger Ilya | Chief Operating Officer | Sell | 5,000 | $47.00 | $235.0K | 26,475 |
| Jan 10, 2024 | Weinberg Eric | Chief Commercial Officer | Sell | 10,000 | $46.00 | $460.0K | 319,978 |
| Jan 9, 2024 | Corley Jesse Anderson | Sell | 2,000 | $45.03 | $90.1K | 11,625 | |
| Jan 9, 2024 | Goldshleger Ilya | Chief Operating Officer | Sell | 15,000 | $43.33 | $650.0K | 36,475-29% |
| Jan 9, 2024 | Kurtz Ronald M MD | President & CEO | Sell | 62,500 | $44.25 | $2.77M | 835,860 |
| Jan 9, 2024 | Maniar Shweta | Sell | 6,418 | $45.00 | $288.8K | 18,529-26% |
Showing 1–50 of 79
1 / 2
RXST Insider Buying Activity
The following table shows recent insider purchases of RxSight, Inc. (RXST) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 17, 2025 | Corley Jesse Anderson | Buy | 3,210 | $31.15 | $100.0K | 3,210 | |
| Nov 14, 2024 | Corley Jesse Anderson | Buy | 22,476 | $45.14 | $1.01M | 474,141 | |
| May 21, 2024 | Tammenoms Bakker Juliet | Buy | 5,000 | $61.09 | $305.5K | 34,840 | |
| Feb 15, 2024 | Tammenoms Bakker Juliet | Buy | 8,000 | $50.83 | $406.7K | 29,840+37% |
RXST Insider Selling Activity
The following table shows recent insider sales of RxSight, Inc. (RXST) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Goldshleger Ilya | officer: Chief Operating Officer | Sell | 2,041 | $6.96 | $14.2K | 81,509 |
| Sep 2, 2026 | Kurtz Ronald M MD | officer: Chief Medical Officer | Sell | 5,100 | $6.96 | $35.5K | 71,775 |
| Sep 2, 2026 | Weinberg Eric | officer: See remarks | Sell | 2,041 | $6.96 | $14.2K | 200,348 |
| Sep 2, 2026 | Wilterding Mark | officer: Chief Financial Officer | Sell | 7,765 | $6.96 | $54.0K | 25,049 |
| Mar 12, 2025 | Fountain Tamara | Director | Sell | 7,000 | $25.71 | $180.0K | 0 |
| Jan 27, 2025 | Maniar Shweta | Sell | 3,519 | $30.87 | $108.6K | 7,383-32% | |
| Dec 3, 2024 | Goldshleger Ilya | See remarks | Sell | 3,105 | $46.08 | $143.1K | 42,246 |
| Nov 26, 2024 | Goldshleger Ilya | See remarks | Sell | 6,200 | $45.44 | $281.7K | 42,246 |
| Nov 26, 2024 | Maniar Shweta | Sell | 3,782 | $45.88 | $173.5K | 10,902-26% | |
| Nov 18, 2024 | Goldshleger Ilya | See remarks | Sell | 7,975 | $45.61 | $363.8K | 42,279 |
| Nov 14, 2024 | Goldshleger Ilya | See remarks | Sell | 1,330 | $46.13 | $61.4K | 42,246 |
| Nov 8, 2024 | Goldshleger Ilya | See remarks | Sell | 3,100 | $55.00 | $170.5K | 42,446 |
| Nov 5, 2024 | Goldshleger Ilya | See remarks | Sell | 3,100 | $51.05 | $158.2K | 42,506 |
| Oct 31, 2024 | Goldshleger Ilya | See remarks | Sell | 3,105 | $51.91 | $161.2K | 42,246 |
| Oct 28, 2024 | Goldshleger Ilya | See remarks | Sell | 6,200 | $50.22 | $311.4K | 42,246 |
| Oct 22, 2024 | Goldshleger Ilya | See remarks | Sell | 3,100 | $49.68 | $154.0K | 42,246 |
| Oct 18, 2024 | Goldshleger Ilya | See remarks | Sell | 6,205 | $49.94 | $309.9K | 42,349 |
| Oct 15, 2024 | Goldshleger Ilya | See remarks | Sell | 9,305 | $49.70 | $462.5K | 42,246 |
| Oct 8, 2024 | Goldshleger Ilya | See remarks | Sell | 6,200 | $48.13 | $298.4K | 42,480 |
| Oct 2, 2024 | Thunen Shelley B | See remarks | Sell | 15,000 | $48.45 | $726.7K | 40,242-27% |
| Sep 30, 2024 | Goldshleger Ilya | See remarks | Sell | 6,205 | $49.15 | $305.0K | 43,694 |
| Sep 23, 2024 | Goldshleger Ilya | See remarks | Sell | 6,200 | $52.93 | $328.2K | 42,396 |
| Sep 18, 2024 | Goldshleger Ilya | See remarks | Sell | 3,100 | $56.11 | $173.9K | 42,246 |
| Aug 6, 2024 | Goldshleger Ilya | See remarks | Sell | 9,000 | $39.25 | $353.3K | 50,101 |
| Jul 2, 2024 | Thunen Shelley B | Chief Financial Officer | Sell | 18,402 | $58.68 | $1.08M | 15,792-54% |
| Jun 17, 2024 | Andrews Julie | Sell | 15,625 | $58.00 | $906.3K | 33,972-32% | |
| May 6, 2024 | Kurtz Ronald M MD | President & CEO | Sell | 40,000 | $60.15 | $2.41M | 764,610 |
| May 2, 2024 | Thunen Shelley B | Chief Financial Officer | Sell | 10,000 | $52.69 | $526.9K | 14,318-41% |
| Apr 2, 2024 | Thunen Shelley B | Chief Financial Officer | Sell | 20,000 | $49.90 | $997.9K | 19,545-51% |
| Mar 5, 2024 | Thunen Shelley B | Chief Financial Officer | Sell | 10,000 | $56.37 | $563.7K | 22,525-31% |
| Feb 16, 2024 | Goldshleger Ilya | Chief Operating Officer | Sell | 25,000 | $54.00 | $1.35M | 31,475-44% |
| Feb 12, 2024 | Goldshleger Ilya | Chief Operating Officer | Sell | 10,365 | $50.74 | $525.9K | 31,475 |
| Feb 7, 2024 | Thunen Shelley B | Chief Financial Officer | Sell | 15,875 | $47.47 | $753.6K | 13,691-54% |
| Feb 2, 2024 | Goldshleger Ilya | Chief Operating Officer | Sell | 7,129 | $49.29 | $351.4K | 30,065 |
| Feb 2, 2024 | LINK WILLIAM J PHD | Sell | 28,250 | $49.67 | $1.40M | 31,900-47% | |
| Feb 2, 2024 | Weinberg Eric | Chief Commercial Officer | Sell | 10,000 | $50.00 | $500.0K | 299,978 |
| Jan 29, 2024 | Thunen Shelley B | Chief Financial Officer | Sell | 31,772 | $47.11 | $1.50M | 6,791-82% |
| Jan 22, 2024 | Goldshleger Ilya | Chief Operating Officer | Sell | 5,000 | $48.00 | $240.0K | 26,475 |
| Jan 22, 2024 | Weinberg Eric | Chief Commercial Officer | Sell | 10,000 | $48.00 | $480.0K | 309,978 |
| Jan 19, 2024 | Maniar Shweta | Sell | 6,399 | $45.72 | $292.6K | 15,009-30% | |
| Jan 10, 2024 | Goldshleger Ilya | Chief Operating Officer | Sell | 5,000 | $47.00 | $235.0K | 26,475 |
| Jan 10, 2024 | Weinberg Eric | Chief Commercial Officer | Sell | 10,000 | $46.00 | $460.0K | 319,978 |
| Jan 9, 2024 | Corley Jesse Anderson | Sell | 2,000 | $45.03 | $90.1K | 11,625 | |
| Jan 9, 2024 | Goldshleger Ilya | Chief Operating Officer | Sell | 15,000 | $43.33 | $650.0K | 36,475-29% |
| Jan 9, 2024 | Kurtz Ronald M MD | President & CEO | Sell | 62,500 | $44.25 | $2.77M | 835,860 |
| Jan 9, 2024 | Maniar Shweta | Sell | 6,418 | $45.00 | $288.8K | 18,529-26% |
RXST Insiders
Similar Stocks to RXST
SYK
Stryker Corporation
$281.11-0.32%
$105.57B
BSX
Boston Scientific Corporation
$43.93-2.48%
$66.83B
EW
Edwards Lifesciences Corporation
$85.82+0.33%
$49.62B
DXCM
DexCom, Inc.
$86.69+2.37%
$31.33B
ZBH
Zimmer Biomet Holdings, Inc.
$99.10+2.61%
$18.09B
GMED
Globus Medical, Inc.
$74.78-1.29%
$10.01B
GKOS
Glaukos Corporation
$172.13+0.61%
$9.87B
PODD
Insulet Corp.
$139.63+1.32%
$9.14B